Breast CancerNCT06371625
U/S Guided Transversus Thoracic and Pectoral Nerve Block Versus Pectoral Nerve Block in MRM
A study testing Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block and Pectoral Nerves (PECS) Block in people with Breast Cancer and Analgesia, run by Ahmed Mohamed Soliman at 3 sites in Egypt.
Trial summary
Interfascial blocks score over regional anesthetic techniques such as Transversus Thoracic Plane Block and Pectoral Nerves (PECS) Block as they have no risk of sympathetic blockade, intrathecal or epidural spread, which may lead to hemodynamic instability and prolonged hospital stay. Read more about this study
- Who is it for?
- Ages 20 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Breast Cancer, Analgesia
- What is being tested?
- Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block and Pectoral Nerves (PECS) Block
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 22 participants
- Where
- 3 sitesEgypt
- Study dates
- 2 Jul 2022to 1 Oct 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- female patients.
- type of surgery: MRM
- ASA I, II, III
- BMI >20 kg/m2 and <35 kg/m2
Who cannot join
- BMI <20 kg/m2 and >35 kg/m2
- known sensitivity or contraindication to drugs used
- history of psychological disorders.
- patient refusal
- pregnancy
- contraindication to regional anesthesia e.g. local sepsis, pre-existing peripheral neuropathy and coagulopathy
Trial locations and contacts
3 sites in 1 country.
Egypt3 sites
National cancer Insititute Cairo university
Cairo, 11796
National cancer Insititute
Cairo, 11796
Ahmed Mohamed Soliman
Giza
About this study
Official title: Ultrasound Guided Transversus Thoracic and Pectoral Nerve Block Versus Pectoral Nerve Block in Modified Radical Mastectomy
Interfascial blocks score over regional anesthetic techniques such as Transversus Thoracic Plane Block and Pectoral Nerves (PECS) Block as they have no risk of sympathetic blockade, intrathecal or epidural spread, which may lead to hemodynamic instability and prolonged hospital stay. The transversus thoracic muscle plane block (TTP) block is a newly developed regional anesthesia technique which provides analgesia to the anterior chest wall. First described by Ueshima et al. in 2015, the TTP block is a single-shot nerve block that deposits local anesthetic in the transversus thoracic muscle plane between the internal intercostal and transversus thoracic muscles. TTP block targets the anterior branches of the intercostal nerves (T2-6).
Pectoral plane blocks are recently described . PECS block involves deposition of local anesthetic drug between muscle planes. PECS I block, between Pectoralis Major and Minor at third rib level, and PECS II block, the drug is deposited between Pectoralis minor and Serratus anterior muscle.
The pectoral nerves (PECS) block provides analgesia of the lateral mammary region, the intercostobrachial and lateral cutaneous branches of the intercostal nerves (T2-T6), the medial cutaneous nerve of the arm and forearm, and the long thoracic and thoracodorsal nerves. The modified PECS block produces excellent analgesia and can be used to provide balanced anesthesia.
Read the detailed description
Background and Rationale:
Breast cancer is one of the common malignancies among women. Surgical resection of the primary tumor with axillary dissection is one of the main modalities of breast cancer treatment. The most common modality for anesthesia is general anesthesia with or without regional blocks. It has been reported that 40% of females report moderate to severe pain in the immediate post-operative period after breast cancer surgery. Acute post-surgical pain leads to delayed discharge from post-operative recovery area, impairs pulmonary and immune functions, increases risk of ileus, thromboembolism, myocardial infarction and may lead to increased length of hospital stay.
It is also an important factor leading to the development of chronic persistent post-operative pain in almost half of the patients. Post-operative pain, stress and use of morphine have been elucidated as factors responsible for increased risk of metastasis. Hence, effective perioperative pain management of patients undergoing breast surgery is essential. Regional blocks have been considered one of the modalities for effective perioperative pain control. They have an opioid-sparing effect and allow early mobilization and early discharge from the hospital.
Interfascial blocks score over regional anesthetic techniques such as Transversus Thoracic Plane Block and Pectoral Nerves (PECS) Block as they have no risk of sympathetic blockade, intrathecal or epidural spread, which may lead to hemodynamic instability and prolonged hospital stay. The transversus thoracic muscle plane block (TTP) block is a newly developed regional anesthesia technique which provides analgesia to the anterior chest wall. First described by Ueshima et al. in 2015, the TTP block is a single-shot nerve block that deposits local anesthetic in the transversus thoracic muscle plane between the internal intercostal and transversus thoracic muscles. TTP block targets the anterior branches of the intercostal nerves (T2-6).
Pectoral plane blocks are recently described . PECS block involves deposition of local anesthetic drug between muscle planes. PECS I block, between Pectoralis Major and Minor at third rib level, and PECS II block, the drug is deposited between Pectoralis minor and Serratus anterior muscle.
The pectoral nerves (PECS) block provides analgesia of the lateral mammary region, the intercostobrachial and lateral cutaneous branches of the intercostal nerves (T2-T6), the medial cutaneous nerve of the arm and forearm, and the long thoracic and thoracodorsal nerves. The modified PECS block produces excellent analgesia and can be used to provide balanced anesthesia.
Study Methodology:
- Population of the study:
Female patients 20-60 years old undergoing Modified Radical Mastectomy will be enrolled in our study. They will be randomized into two comparable groups:
Group A (patients): They will receive ultrasound-guided Transversus Thoracic Plane Block, Pectoral Nerves (PECS) Block, and General anesthesia.
Group B (patients): Will receive Pectoral Nerves (PECS) Block and General Anesthesia.
Interventions:
- Patient preparation:
All included patients will undergo the following: History taking, physical examination, CBC and coagulation profile. They will be informed about the procedure and its possible complications. Finally, written consent will be taken. They will randomly be allocated into two groups using computer generated random numbers.
Both groups will receive Pectoral Nerves (PECS) Block and General Anesthesia. Group (A) Will have in addition to this anesthesia, Transversus Thoracic Plane Block.
- Procedures: All patients will be kept fasting overnight and will be pre-medicated with midazolam 2mg and 500 ml lactated ringer's solutions will be infused 30 minutes before surgery and will be fully monitored by ECG, blood pressure and pulse oximetry. The ultrasound device (Sonosite M-Turbo C 04TRGD) with a 10-12 MHZ linear array probe (HFL38) will be used.
Group (A): Will receive Transversus Thoracic Plane Block with bupivacaine 0.25% 15ml single injection at same side at T4-T5 level before induction of General Anesthesia. The block will be performed under complete aseptic precautions with a 22 gauge echogenic needle using the same ultrasound machine and linear array probe by an anesthetist not involved in the preoperative assessment of the patient, anesthesia management and data collection.
Group (B): Will receive Pectoral Nerves (PECS) Block and General Anesthesia.
Transeversus Thoracic Plane Block (TTPB) [Group A]:
The TTP block will be performed in a supine position before general anesthesia. First, a high linear probe of the ultrasound system will be attached at sagittal plane to the sternum and counted from T2 near the clavicle to T5. Then the linear probe will be rotated by 90° and attached between the forth and the fifth costal cartilages connecting at the sternum near nipple. Then, the transversus thoracic muscle and the internal intercostal muscle will be identified. A total of 15 mL of 0.25% bupivacaine will be injected into the interfascial plane, between the transversus thoracic muscle and the internal intercostal muscle between the fourth and fifth costal cartilages connecting at the sternum. Pleural downward displacement will be used as an ultrasound endpoint. After the injection, the spread of local anesthetic will be confirmed by using the probe.
Pectoral Nerves (PECS) Block [Both Groups] :
Patients will be positioned supine with the ipsilateral arm abducted and externally rotated. The infra-clavicular and axillary regions will be cleaned with chlorhexidine. The skin point of puncture will be infiltrated with 2% lidocaine and once the structures are identified with ultrasound, the probe will be positioned under the lateral third of the clavicle. After locating the subclavian artery, the axillary artery and the axillary vein we will move the probe distally towards the axilla, until the pectorals major muscle is identified. We will start counting the ribs, from 1st rib under the axillary artery and maintaining the pectorals major as a reference, we will move distally and laterally until the lateral border of pectorals major is reached. Serratus anterior muscle cover 2nd, 3rd, 4th rib, this point being the entrance into the anterior axillary line we will use atraumatic needle with extension line and electrode for nerve stimulator (Stimuplex D). We will use one needle approaches instead of two. We will inject 10ml of 0.25% bupivacaine between the pectorals muscles firstly then inject 20ml of 0.25% bupivacaine between the pectorals major muscle and the serratus muscle. The block will be performed with the patient fully awake, followed by general anesthesia.
Both groups will receive General Anesthesia:
- Induction: propofol 1.5-2mg/kg, fentanyl 1ug/kg and Atracurium 0.5mg/kg.
- Intubation: Endotracheal Intubation with appropriate size.
- Maintenance: Isoflurane, fentanyl and Atracurium (0.1-0.2 mg/kg), according to Train of Four Monitoring. Additional boluses of fentanyl (0.3ug/kg) will be administered to maintain mean arterial blood pressure or heart rate values within 30% of baseline vital signs when the patient entered the operating room. Fentanyl frequency and amount will be documented.
- Monitoring: SPO2, ECG, non-invasive blood pressure (before induction, after tracheal intubation, at skin incision, and then every 5 minutes).
- Maintenance fluids: lactated ringer will be given according to fluid chart maintenance, deficit, third space, and urine output and blood loss.
Methodology:
Age, weight, and duration of Anesthesia will be documented. HR in beats per minute, mean arterial blood pressure (MABP), and ECG changes will be monitored and recorded at the following periods: preoperative, after block, after induction of Anesthesia, at skin incision, and then every 5 min. till the end of the surgery.
Postoperative HR , mean arterial blood pressure ,ECG changes, oxygen saturation of the room air, respiratory rate, assessing pain using VAS score, time to first analgesia request, quantity and frequency of opioid requirements will continuously be monitored and recorded at the following periods: at PACU admission, at 1, 2, 4, 6, 12, and 24 h after surgery at rest., Group (B) will receive Pectoral Nerves (PECS) Block and General Anesthesia).
Sample size:
The aim of this study is to measure the postoperative pain score scale (VAS) in 2 groups of MRM patients (Group A (experimental group) will receive ultrasound guided Transversus Thoracic Plane Block, Pectoral Nerves Block and General anesthesia while Group B (control group) will receive Pectoral Nerves Block and General Anesthesia). Based on a previous study by Ueshima and Otake (2017); the median visual analog scale (VAS) score (in millimetres at rest) at 12 hours postoperatively among the experimental group (who received ultrasound guided Transversus Thoracic Plane Block, Pectoral Nerves Block and General anesthesia) was 14 mm and ranged from (5-18 mm) while the median VAS score at the same time point among the control group (who received Pectoral Nerves Block and General Anesthesia) was 30 mm and ranged from (15-59 mm). A total sample size of 22 MRM patients (11 per group) will be needed for this study with type I error (alpha) 5% and type II error (Beta) 1%. This sample will be increased by 15% (to compensate for non-parametric use) to be 26. To allow for 25% expected losses, the sample will be further increased to 34 MRM patients (17 in each group). Sample size estimation was performed by MedCalc Statistical Software version 14.8.1.
- Conditions
- Breast Cancer, Analgesia
- Being tested
- Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block, Pectoral Nerves (PECS) Block
- Keywords
- Breast Neoplasms, Analgesics, Opioids, Postoperative Pain, Mastectomy, Nerve block
- Medical subject headings
- Breast Neoplasms, Agnosia, Pain, Postoperative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) BlockProcedure or surgery
The TTP block will be performed in a supine position before general anesthesia. First, a high linear probe of the ultrasound system will be attached at sagittal plane to the sternum and counted from T2 near the clavicle to T5. Then the linear probe will be rotated by 90° and attached between the forth and the fifth costal cartilages connecting at the sternum near nipple. Then, the transversus thoracic muscle and the internal intercostal muscle will be identified. A total of 15 mL of 0.25% bupivacaine will be injected into the interfascial plane, between the transversus thoracic muscle and the internal intercostal muscle between the fourth and fifth costal cartilages connecting at the sternum. Pleural downward displacement will be used as an ultrasound endpoint.
Pectoral Nerves (PECS) BlockProcedure or surgery
Patients positioned supine with the ipsilateral arm abducted and externally rotated. The infra-clavicular and axillary regions will be cleaned with chlorhexidine. The skin point of and once the structures are identified with ultrasound, the probe will be positioned under the lateral third of the clavicle. After locating the subclavian artery, the axillary artery and the axillary vein we will move the probe distally towards the axilla, until the pectorals major muscle is identified. We will start counting the ribs, from 1st rib under the axillary artery and maintaining the pectorals major. Serratus anterior muscle cover 2nd, 3rd, 4th rib, this point being the entrance into the anterior axillary line we will use atraumatic needle with extension line and electrode for nerve stimulator (Stimuplex D). We will inject 10ml of 0.25% bupivacaine between the pectorals muscles first, then inject 20ml of 0.25% bupivacaine.
| Study group | Role | What they receive |
|---|---|---|
| Transeversus Thoracic Plane Block (TTPB) [Group A]: | Active comparator | block performed in a supine position before general anesthesia. Linear probe of the ultrasound system will be attached at sagittal plane to the sternum and counted from T2 near the clavicle to T5. Then the linear probe will be rotated by 90° and attached between the forth and the fifth costal cartilages connecting at the sternum near nipple. Then, the transversus thoracic muscle and the internal intercostal muscle will be identified. Receives: Procedure: Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block |
| Pectoral Nerves (PECS) Block [Both Groups] : | Active comparator | Positioned supine with the ipsilateral arm abducted and externally rotated. The infra-clavicular and axillary regions will be cleaned with chlorhexidine. The probe will be positioned under the lateral third of the clavicle. After locating the subclavian artery, the axillary artery and the axillary vein we will move the probe distally towards the axilla, until the pectorals major muscle is identified. We will start counting the ribs, from 1st rib under the axillary artery and maintaining the pectorals major as a reference, we will move distally and laterally until the lateral border of pectorals major is reached. Serratus anterior muscle cover 2nd, 3rd, 4th rib, this point being the entrance into the anterior axillary line we will use atraumatic needle with extension line and electrode for nerve stimulator (Stimuplex D). Receives: Procedure: Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block; Procedure: Pectoral Nerves (PECS) Block |
What is being measured
The primary outcome is the main question the study is designed to answer.
total morphine consumption
total morphine consumption as iv analgesic
Measured: 24 hours postoperatively
Secondary outcomes (4)
visual analogue scale "VAS score"
visual analogue scale as zero "No pain" and 10 "maximum pain"
Measured: 24 hours postoperative
mean blood pressure
mean blood pressure changes
Measured: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively
heart rate
heart rate change
Measured: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively
first analgesic dose
time of first analgesic dose
Measured: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2024
- Study start2 Jul 2022
- Primary completion1 Aug 2023
- Study completion1 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Breast CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- to determine the analgesic effect of ultrasound guided Transversus Thoracic and Pectoral Nerve Block compared to ultrasound guided Pectoral Nerve Block in patients undergoing modified radical mastectomy regarding the following : 1-Post-operative opioid (morphine) consumption in the 1st 24 hours 2- Postoperative Numeric Pain Rating Scale. 3. Effect on hemodynamics: Mean arterial blood pressure and Heart rate. 4. Intraoperative fentanyl consumption. 5. Duration of analgesic effect
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 22 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ahmed Mohamed Soliman
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Ahmed Mohamed Soliman, National Cancer Institute, Egypt
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06371625
- Sponsor's protocol ID
- AP2202-30104
- Status last verified
- Jul 2024
- First submitted
- 14 Apr 2024
- Last updated
- 9 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: till publication
Study at a glance
From the registry record, last updated by the sponsor on 9 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ultrasound Guided Transversus Thoracic and Pectoral Nerve Block Versus Pectoral Nerve Block in Modified Radical Mastectomy
- ClinicalTrials.gov ID
- NCT06371625
- Acronym / sponsor ID
- AP2202-30104
- Conditions
- Breast Cancer, Analgesia
- Keywords
- Breast Neoplasms, Analgesics, Opioids, Postoperative Pain, Mastectomy, Nerve block
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 22 participants (actual)
- Lead sponsor
- Ahmed Mohamed SolimanUniversity, hospital or other
- Study start
- 2 Jul 2022 (actual)
- Primary completion
- 1 Aug 2023 (actual)
- Study completion
- 1 Oct 2023 (actual)
- First posted
- 17 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Interfascial blocks score over regional anesthetic techniques such as Transversus Thoracic Plane Block and Pectoral Nerves (PECS) Block as they have no risk of sympathetic blockade, intrathecal or epidural spread, which may lead to hemodynamic instability and prolonged hospital stay. The transversus thoracic muscle plane block (TTP) block is a newly developed regional anesthesia technique which provides analgesia to the anterior chest wall. First described by Ueshima et al. in 2015, the TTP block is a single-shot nerve block that deposits local anesthetic in the transversus thoracic muscle plane between the internal intercostal and transversus thoracic muscles. TTP block targets the anterior branches of the intercostal nerves (T2-6).
Pectoral plane blocks are recently described . PECS block involves deposition of local anesthetic drug between muscle planes. PECS I block, between Pectoralis Major and Minor at third rib level, and PECS II block, the drug is deposited between Pectoralis minor and Serratus anterior muscle.
The pectoral nerves (PECS) block provides analgesia of the lateral mammary region, the intercostobrachial and lateral cutaneous branches of the intercostal nerves (T2-T6), the medial cutaneous nerve of the arm and forearm, and the long thoracic and thoracodorsal nerves. The modified PECS block produces excellent analgesia and can be used to provide balanced anesthesia.
Detailed description
Background and Rationale:
Breast cancer is one of the common malignancies among women. Surgical resection of the primary tumor with axillary dissection is one of the main modalities of breast cancer treatment. The most common modality for anesthesia is general anesthesia with or without regional blocks. It has been reported that 40% of females report moderate to severe pain in the immediate post-operative period after breast cancer surgery. Acute post-surgical pain leads to delayed discharge from post-operative recovery area, impairs pulmonary and immune functions, increases risk of ileus, thromboembolism, myocardial infarction and may lead to increased length of hospital stay.
It is also an important factor leading to the development of chronic persistent post-operative pain in almost half of the patients. Post-operative pain, stress and use of morphine have been elucidated as factors responsible for increased risk of metastasis. Hence, effective perioperative pain management of patients undergoing breast surgery is essential. Regional blocks have been considered one of the modalities for effective perioperative pain control. They have an opioid-sparing effect and allow early mobilization and early discharge from the hospital.
Interfascial blocks score over regional anesthetic techniques such as Transversus Thoracic Plane Block and Pectoral Nerves (PECS) Block as they have no risk of sympathetic blockade, intrathecal or epidural spread, which may lead to hemodynamic instability and prolonged hospital stay. The transversus thoracic muscle plane block (TTP) block is a newly developed regional anesthesia technique which provides analgesia to the anterior chest wall. First described by Ueshima et al. in 2015, the TTP block is a single-shot nerve block that deposits local anesthetic in the transversus thoracic muscle plane between the internal intercostal and transversus thoracic muscles. TTP block targets the anterior branches of the intercostal nerves (T2-6).
Pectoral plane blocks are recently described . PECS block involves deposition of local anesthetic drug between muscle planes. PECS I block, between Pectoralis Major and Minor at third rib level, and PECS II block, the drug is deposited between Pectoralis minor and Serratus anterior muscle.
The pectoral nerves (PECS) block provides analgesia of the lateral mammary region, the intercostobrachial and lateral cutaneous branches of the intercostal nerves (T2-T6), the medial cutaneous nerve of the arm and forearm, and the long thoracic and thoracodorsal nerves. The modified PECS block produces excellent analgesia and can be used to provide balanced anesthesia.
Study Methodology:
- Population of the study:
Female patients 20-60 years old undergoing Modified Radical Mastectomy will be enrolled in our study. They will be randomized into two comparable groups:
Group A (patients): They will receive ultrasound-guided Transversus Thoracic Plane Block, Pectoral Nerves (PECS) Block, and General anesthesia.
Group B (patients): Will receive Pectoral Nerves (PECS) Block and General Anesthesia.
Interventions:
- Patient preparation:
All included patients will undergo the following: History taking, physical examination, CBC and coagulation profile. They will be informed about the procedure and its possible complications. Finally, written consent will be taken. They will randomly be allocated into two groups using computer generated random numbers.
Both groups will receive Pectoral Nerves (PECS) Block and General Anesthesia. Group (A) Will have in addition to this anesthesia, Transversus Thoracic Plane Block.
- Procedures: All patients will be kept fasting overnight and will be pre-medicated with midazolam 2mg and 500 ml lactated ringer's solutions will be infused 30 minutes before surgery and will be fully monitored by ECG, blood pressure and pulse oximetry. The ultrasound device (Sonosite M-Turbo C 04TRGD) with a 10-12 MHZ linear array probe (HFL38) will be used.
Group (A): Will receive Transversus Thoracic Plane Block with bupivacaine 0.25% 15ml single injection at same side at T4-T5 level before induction of General Anesthesia. The block will be performed under complete aseptic precautions with a 22 gauge echogenic needle using the same ultrasound machine and linear array probe by an anesthetist not involved in the preoperative assessment of the patient, anesthesia management and data collection.
Group (B): Will receive Pectoral Nerves (PECS) Block and General Anesthesia.
Transeversus Thoracic Plane Block (TTPB) [Group A]:
The TTP block will be performed in a supine position before general anesthesia. First, a high linear probe of the ultrasound system will be attached at sagittal plane to the sternum and counted from T2 near the clavicle to T5. Then the linear probe will be rotated by 90° and attached between the forth and the fifth costal cartilages connecting at the sternum near nipple. Then, the transversus thoracic muscle and the internal intercostal muscle will be identified. A total of 15 mL of 0.25% bupivacaine will be injected into the interfascial plane, between the transversus thoracic muscle and the internal intercostal muscle between the fourth and fifth costal cartilages connecting at the sternum. Pleural downward displacement will be used as an ultrasound endpoint. After the injection, the spread of local anesthetic will be confirmed by using the probe.
Pectoral Nerves (PECS) Block [Both Groups] :
Patients will be positioned supine with the ipsilateral arm abducted and externally rotated. The infra-clavicular and axillary regions will be cleaned with chlorhexidine. The skin point of puncture will be infiltrated with 2% lidocaine and once the structures are identified with ultrasound, the probe will be positioned under the lateral third of the clavicle. After locating the subclavian artery, the axillary artery and the axillary vein we will move the probe distally towards the axilla, until the pectorals major muscle is identified. We will start counting the ribs, from 1st rib under the axillary artery and maintaining the pectorals major as a reference, we will move distally and laterally until the lateral border of pectorals major is reached. Serratus anterior muscle cover 2nd, 3rd, 4th rib, this point being the entrance into the anterior axillary line we will use atraumatic needle with extension line and electrode for nerve stimulator (Stimuplex D). We will use one needle approaches instead of two. We will inject 10ml of 0.25% bupivacaine between the pectorals muscles firstly then inject 20ml of 0.25% bupivacaine between the pectorals major muscle and the serratus muscle. The block will be performed with the patient fully awake, followed by general anesthesia.
Both groups will receive General Anesthesia:
- Induction: propofol 1.5-2mg/kg, fentanyl 1ug/kg and Atracurium 0.5mg/kg.
- Intubation: Endotracheal Intubation with appropriate size.
- Maintenance: Isoflurane, fentanyl and Atracurium (0.1-0.2 mg/kg), according to Train of Four Monitoring. Additional boluses of fentanyl (0.3ug/kg) will be administered to maintain mean arterial blood pressure or heart rate values within 30% of baseline vital signs when the patient entered the operating room. Fentanyl frequency and amount will be documented.
- Monitoring: SPO2, ECG, non-invasive blood pressure (before induction, after tracheal intubation, at skin incision, and then every 5 minutes).
- Maintenance fluids: lactated ringer will be given according to fluid chart maintenance, deficit, third space, and urine output and blood loss.
Methodology:
Age, weight, and duration of Anesthesia will be documented. HR in beats per minute, mean arterial blood pressure (MABP), and ECG changes will be monitored and recorded at the following periods: preoperative, after block, after induction of Anesthesia, at skin incision, and then every 5 min. till the end of the surgery.
Postoperative HR , mean arterial blood pressure ,ECG changes, oxygen saturation of the room air, respiratory rate, assessing pain using VAS score, time to first analgesia request, quantity and frequency of opioid requirements will continuously be monitored and recorded at the following periods: at PACU admission, at 1, 2, 4, 6, 12, and 24 h after surgery at rest., Group (B) will receive Pectoral Nerves (PECS) Block and General Anesthesia).
Sample size:
The aim of this study is to measure the postoperative pain score scale (VAS) in 2 groups of MRM patients (Group A (experimental group) will receive ultrasound guided Transversus Thoracic Plane Block, Pectoral Nerves Block and General anesthesia while Group B (control group) will receive Pectoral Nerves Block and General Anesthesia). Based on a previous study by Ueshima and Otake (2017); the median visual analog scale (VAS) score (in millimetres at rest) at 12 hours postoperatively among the experimental group (who received ultrasound guided Transversus Thoracic Plane Block, Pectoral Nerves Block and General anesthesia) was 14 mm and ranged from (5-18 mm) while the median VAS score at the same time point among the control group (who received Pectoral Nerves Block and General Anesthesia) was 30 mm and ranged from (15-59 mm). A total sample size of 22 MRM patients (11 per group) will be needed for this study with type I error (alpha) 5% and type II error (Beta) 1%. This sample will be increased by 15% (to compensate for non-parametric use) to be 26. To allow for 25% expected losses, the sample will be further increased to 34 MRM patients (17 in each group). Sample size estimation was performed by MedCalc Statistical Software version 14.8.1.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- to determine the analgesic effect of ultrasound guided Transversus Thoracic and Pectoral Nerve Block compared to ultrasound guided Pectoral Nerve Block in patients undergoing modified radical mastectomy regarding the following : 1-Post-operative opioid (morphine) consumption in the 1st 24 hours 2- Postoperative Numeric Pain Rating Scale. 3. Effect on hemodynamics: Mean arterial blood pressure and Heart rate. 4. Intraoperative fentanyl consumption. 5. Duration of analgesic effect
| Arm | Type | Receives |
|---|---|---|
| Transeversus Thoracic Plane Block (TTPB) [Group A]: | Active comparator | Procedure: Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Blockblock performed in a supine position before general anesthesia. Linear probe of the ultrasound system will be attached at sagittal plane to the sternum and counted from T2 near the clavicle to T5. Then the linear probe will be rotated by 90° and attached between the forth and the fifth costal cartilages connecting at the sternum near nipple. Then, the transversus thoracic muscle and the internal intercostal muscle will be identified. |
| Pectoral Nerves (PECS) Block [Both Groups] : | Active comparator | Procedure: Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block, Procedure: Pectoral Nerves (PECS) BlockPositioned supine with the ipsilateral arm abducted and externally rotated. The infra-clavicular and axillary regions will be cleaned with chlorhexidine. The probe will be positioned under the lateral third of the clavicle. After locating the subclavian artery, the axillary artery and the axillary vein we will move the probe distally towards the axilla, until the pectorals major muscle is identified. We will start counting the ribs, from 1st rib under the axillary artery and maintaining the pectorals major as a reference, we will move distally and laterally until the lateral border of pectorals major is reached. Serratus anterior muscle cover 2nd, 3rd, 4th rib, this point being the entrance into the anterior axillary line we will use atraumatic needle with extension line and electrode for nerve stimulator (Stimuplex D). |
Who may qualify
- Ages
- 20 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- female patients.
- type of surgery: MRM
- ASA I, II, III
- BMI >20 kg/m2 and <35 kg/m2
Key exclusion criteria (6 listed)
- BMI <20 kg/m2 and >35 kg/m2
- known sensitivity or contraindication to drugs used
- history of psychological disorders.
- patient refusal
- pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) BlockThe TTP block will be performed in a supine position before general anesthesia. First, a high linear probe of the ultrasound system will be attached at sagittal plane to the sternum and counted from T2 near the clavicle to T5. Then the linear probe will be rotated by 90° and attached between the forth and the fifth costal cartilages connecting at the sternum near nipple. Then, the transversus thoracic muscle and the internal intercostal muscle will be identified. A total of 15 mL of 0.25% bupivacaine will be injected into the interfascial plane, between the transversus thoracic muscle and the internal intercostal muscle between the fourth and fifth costal cartilages connecting at the sternum. Pleural downward displacement will be used as an ultrasound endpoint. | Procedure or surgery | Pectoral Nerves (PECS) Block [Both Groups] :, Transeversus Thoracic Plane Block (TTPB) [Group A]: |
| Pectoral Nerves (PECS) BlockPatients positioned supine with the ipsilateral arm abducted and externally rotated. The infra-clavicular and axillary regions will be cleaned with chlorhexidine. The skin point of and once the structures are identified with ultrasound, the probe will be positioned under the lateral third of the clavicle. After locating the subclavian artery, the axillary artery and the axillary vein we will move the probe distally towards the axilla, until the pectorals major muscle is identified. We will start counting the ribs, from 1st rib under the axillary artery and maintaining the pectorals major. Serratus anterior muscle cover 2nd, 3rd, 4th rib, this point being the entrance into the anterior axillary line we will use atraumatic needle with extension line and electrode for nerve stimulator (Stimuplex D). We will inject 10ml of 0.25% bupivacaine between the pectorals muscles first, then inject 20ml of 0.25% bupivacaine. | Procedure or surgery | Pectoral Nerves (PECS) Block [Both Groups] : |
Primary outcome
total morphine consumption
Time frame: 24 hours postoperatively
total morphine consumption as iv analgesic
4 secondary outcomes
visual analogue scale "VAS score"
Time frame: 24 hours postoperative
mean blood pressure
Time frame: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively
heart rate
Time frame: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively
first analgesic dose
Time frame: at 0, 4, 8, 12, 16, 20 and 24 hours postoperatively
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jul 2024.
- Individual participant dataSharing planned: Undecided. till publication
Related trials for Breast Cancer
Active, not recruitingPhase 2
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7
RecruitingPhase 1/2
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Breast Cancer
Not yet recruiting
Podcast-Based Psychosocial Support for Women Newly Diagnosed With Breast Cancer
Breast Cancer
Recruiting
A Study of Skipping Radiation Therapy in People With Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Active, not recruiting
Dance Study for Post-surgical Pain in Breast Cancer Survivors
Breast Cancer, Survivorship
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block and Pectoral Nerves (PECS) Block in people with Breast Cancer and Analgesia, run by Ahmed Mohamed Soliman at 3 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
total morphine consumption (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2024.